23andMe takes first drug to clinical trial

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured
January 7, 2022

23andMe began a clinical trial for its first drug candidate, the direct-to-consumer DNA testing company said Jan. 6.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News